Seval Bulut | Pharmacology | Best Researcher Award

Assist. Prof. Dr. Seval Bulut | Pharmacology | Best Researcher Award

Erzincan Binali Yıldırım University at Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yıldırım University, Turkey

Dr. Seval Bulut is an accomplished researcher and Assistant Professor in the Department of Pharmacology at Erzincan Binali Yıldırım University in Turkey. With an extensive background in medicine and pharmacology, her research focuses on drug safety, therapeutic interventions, and protective effects of natural extracts on organ function. Dr. Bulut’s prolific work includes 45 research articles published in leading SSCI and SCIE journals, where she has explored biochemical and histopathological mechanisms underlying drug-induced toxicity and protective pharmacological agents. Her studies span organ systems and conditions such as hepatotoxicity, renal damage, reproductive health, and ischemic syndrome, showcasing a robust interdisciplinary approach. Dr. Bulut has contributed to advancing pharmacological research with her findings on natural compounds and coenzyme Q10’s efficacy in mitigating organ dysfunction. Her academic influence extends through her roles as a physician and educator, mentoring emerging researchers in pharmacology. Dr. Bulut’s dedication to drug safety and therapeutic research has not only bolstered her professional reputation but also holds promise for improving patient care and drug efficacy in clinical settings.

Professional Profile

Education

Dr. Seval Bulut’s educational background exemplifies her dedication to the fields of medicine and pharmacology. She earned her MD from Atatürk University Faculty of Medicine in 2001, embarking on her journey as a physician committed to improving patient outcomes. Dr. Bulut later transitioned to academia, pursuing a doctoral program at Erzincan Binali Yıldırım University’s Institute of Health Sciences, Department of Medical Pharmacology. In 2024, she completed her PhD with a thesis titled “The Effect of Liv-52 on Favipiravir-Induced Hepatotoxicity in Rats: Biochemical and Histopathological Evaluation,” demonstrating her keen focus on pharmacology, particularly in drug-induced toxicity. This advanced education has equipped Dr. Bulut with a strong foundation in both clinical and research aspects of pharmacology, enabling her to investigate the biochemical mechanisms of drug interactions and develop therapeutic strategies for organ protection. Her academic journey reflects a consistent focus on integrating medical practice with pharmacological research to address real-world health challenges.

Professional Experience

Dr. Bulut’s professional experience is rooted in her dual roles as a clinician and researcher. She initially practiced medicine across various health institutions from 2001 to 2010, gaining valuable hands-on experience that provided her with a comprehensive understanding of patient care. Transitioning to a Family Physician role between 2010 and 2024, she developed a strong patient-focused perspective, which later became integral to her research approach. Currently, Dr. Bulut serves as an Assistant Professor in the Department of Pharmacology at Erzincan Binali Yıldırım University. In this academic role, she has combined her clinical insights with research expertise, conducting studies on pharmacological interventions to protect against drug-induced organ damage. Her extensive background in clinical medicine complements her current research endeavors, where she investigates the biochemical and histopathological mechanisms of pharmacological agents. This blend of professional experience positions Dr. Bulut as a knowledgeable researcher who brings both theoretical and practical insights to her field.

Research Interests

Dr. Seval Bulut’s research interests lie at the intersection of pharmacology, toxicology, and therapeutic interventions. She is particularly focused on understanding drug-induced toxicity and the protective effects of natural compounds on organ systems. Her work has centered on evaluating the biochemical and histopathological mechanisms of various pharmacological agents, including the impact of drugs such as favipiravir on liver health. Dr. Bulut’s studies also explore natural compounds like coenzyme Q10 and cinnamon extract for their potential to mitigate organ dysfunction, particularly in kidney and liver applications. Additionally, she has examined the effects of pharmaceutical compounds on reproductive health, as well as protective pharmacological strategies for conditions such as ischemic ocular syndrome. Her research contributes to improving drug safety and efficacy, providing insights that could lead to safer clinical applications and therapeutic innovations. Through her interdisciplinary research, Dr. Bulut aims to enhance the understanding of pharmacodynamics and pharmacokinetics in therapeutic contexts.

Research Skills

Dr. Seval Bulut has developed a broad set of research skills essential to her pharmacological studies. She is adept in designing and conducting in vivo experiments, specifically using animal models to assess drug efficacy and toxicity. Her skills in biochemical and histopathological analysis are evidenced in her research on drug-induced organ toxicity, where she utilizes various biochemical markers and staining techniques to evaluate cellular and tissue changes. Dr. Bulut is also proficient in data analysis and interpretation, crucial for her work in pharmacology and toxicology, where she frequently analyzes complex datasets to draw meaningful conclusions about drug interactions and therapeutic effects. Additionally, she is skilled in the ethical and methodological aspects of animal research, ensuring that her studies meet rigorous scientific standards. Her collaborative skills are reflected in her ability to work alongside other professionals, contributing to a multidisciplinary approach in her studies on pharmacological agents and natural compounds.

Awards and Honors

Dr. Seval Bulut’s academic and professional achievements have earned her recognition in the scientific community. Her prolific publication record includes 45 research articles indexed in SSCI and SCIE, which demonstrates her commitment to advancing pharmacological research. These publications span influential journals, highlighting her research’s impact and relevance in the field. Dr. Bulut’s focus on drug safety, natural therapeutics, and organ protection has led to invitations to present her findings at international congresses, further establishing her as a respected voice in pharmacology. Additionally, her progression from a practicing physician to a PhD-holder and Assistant Professor in a highly specialized research area reflects her dedication to both medical practice and academia. Although specific awards are not listed, her consistent scholarly contributions and active research agenda signal her as a promising candidate for future awards recognizing excellence in research and contributions to pharmacology. Her work holds significant implications for clinical safety and therapeutic advancements, which are critical areas of modern medical research.

Conclusion

Dr. Seval Bulut is a strong candidate for the Best Researcher Award due to her significant contributions to pharmacological research and her commitment to addressing drug safety and therapeutic efficacy. Her expertise, publication volume, and applied research focus on organ protection and biochemical evaluation highlight her as an impactful researcher. Continued emphasis on international collaboration, active conference participation, and funding pursuit could further elevate her profile and ensure sustained research advancements.

Publications Top Notes

  1. Title: Effect of ethyl acetate extract from Usnea longissima on chemotherapy-associated multiple organ dysfunction in rats
    Authors: Bingul, E., Bulut, S., Mammadov, R., Suleyman, H., Mendil, A.S.
    Journal: Biomedicine and Pharmacotherapy
    Year: 2024
    Volume: 181
    Article ID: 117636
  2. Title: The hormonal mechanism of the effects of meperidine, sertraline, tianeptine, and their combinations on reproductive functions in female rats
    Authors: Yilmaz, B.K., Suleyman, Z., Suleyman, B., Coban, T.A., Suleyman, H.
    Journal: Biomedicine and Pharmacotherapy
    Year: 2024
    Volume: 178
    Article ID: 117160
  3. Title: Lacidipine, thiamine pyrophosphate and their combination on the ocular ischemic syndrome induced by bilateral common carotid artery ligation
    Authors: Cicek, I., Somuncu, A.M., Altuner, D., Tastan, T.B., Suleyman, H.
    Journal: International Journal of Ophthalmology
    Year: 2024
    Volume: 17, Issue 5
    Pages: 815–821
  4. Title: Effects of adenosine triphosphate, Lacidipine, and Benidipine on 5-fluorouracil-induced kidney damage in rats
    Authors: Dagel, T., Altuner, D., Suleyman, B., Gulaboglu, M., Suleyman, H.
    Journal: European Review for Medical and Pharmacological Sciences
    Year: 2024
    Volume: 28, Issue 6
    Pages: 2538–2549
  5. Title: Comparative study of the protective effects of coenzyme Q10 and cinnamon extract on possible kidney damage and dysfunction of amiodarone in rats
    Authors: Ekici, O., Gul, A., Keskin, E., Gunay, M., Suleyman, H.
    Journal: Clinical and Experimental Nephrology
    Year: 2024
  6. Title: Protective effects of thiamine pyrophosphate and cinnamon against oxidative liver damage induced by an isoniazid and rifampicin combination in rats
    Authors: Yeter, B., Mammadov, R., Koc, Z., Gulaboglu, M., Suleyman, H.
    Journal: Investigacion Clinica (Venezuela)
    Year: 2024
    Volume: 65, Issue 3
    Pages: 321–334
  7. Title: Protective effect of cinnamon extract against cobalt-induced multiple organ damage in rats
    Authors: Isik, B., Suleyman, B., Mammadov, R., Coban, T.A., Suleyman, H.
    Journal: Frontiers in Pharmacology
    Year: 2024
    Volume: 15
    Article ID: 1384181
  8. Title: Role of L-, N- and T-type calcium channels in achieving maximum analgesic and minimum toxic effect of tramadol
    Authors: Yilmaz, M., Suleyman, B., Mammadov, R., Coskun, R., Suleyman, H.
    Journal: Acta Poloniae Pharmaceutica – Drug Research
    Year: 2024
    Volume: 81, Issue 1
    Pages: 135–143
  9. Title: Protective Effect of Ramipril Against Oxidant and Proinflammatory Cytokine Damage Induced by Ischemia-Reperfusion in Ovarian Tissue in Rats
    Authors: Ulug, P., Nayki, U., Mammadov, R., Coban, T.A., Suleyman, H.
    Journal: Transplantation Proceedings
    Year: 2024
    Volume: 56, Issue 1
    Pages: 215–222
  10. Title: Effect of pycnogenol on ischemia/reperfusion-induced oxidative and inflammatory damage in the ovaries of rats
    Authors: Dinc, K., Kiremitli, S., Suleyman, B., Altuner, D., Suleyman, H.
    Journal: Tropical Journal of Pharmaceutical Research
    Year: 2023
    Volume: 22, Issue 11
    Pages: 2297–2303

 

 

Shriyansh Srivastava | Pharmacology Award | Best Researcher Award

Mr. Shriyansh Srivastava | Pharmacology Award | Best Researcher Award

Assistant Professor at Pharmacology Award, Galgotias University, India

Mr. Shriyansh Srivastava is a dedicated professional with a strong academic background and diverse expertise in the field of pharmacology and clinical research. Currently pursuing a PhD at Delhi Pharmaceutical Sciences and Research University, he previously completed his M. Pharm at ISF College of Pharmacy, where he achieved a CGPA of 8.54. With a B. Pharm from Dr. A.P.J. Abdul Kalam Technical University and a 12th-grade education from CRTS Vidya Mandir, Mr. Srivastava’s academic journey demonstrates his commitment to excellence. In addition to his academic achievements, Mr. Srivastava has been serving as an Assistant Professor at Galgotias University since August 31, 2021, focusing on the pharmaceutical field. He has attended various workshops and conferences, showcasing his dedication to continuous learning and professional development. His expertise includes operating advanced laboratory equipment such as the Langendroff Apparatus, fluorescent microscope, and centrifuge. He is also skilled in animal handling, histological studies, and using MS Office applications.

Professional Profiles:

Education:

Mr. Shriyansh Srivastava is currently pursuing a PhD in Pharmacology & Clinical Research at Delhi Pharmaceutical Sciences and Research University, New Delhi, India, from 2022 to the present. He completed his M. Pharm (Pharmacology) at ISF College of Pharmacy, Moga, Punjab, India, from 2019 to 2021, with a CGPA of 8.54. His B. Pharm was completed at Dr. A.P.J. Abdul Kalam Technical University, Lucknow, Uttar Pradesh, India, from 2014 to 2018, with a percentage of 74.82%. In 2013-2014, he completed his 12th grade at CRTS Vidya Mandir, Siswa, Maharajganj, Uttar Pradesh, India, with a percentage of 86.6%.

Professional Experience:

This information describes Mr. Shriyansh Srivastava’s current professional role as an Assistant Professor at Galgotias University. It specifies that he is part of the School of Medical and Allied Sciences, specifically in the Department of Pharmacy. The details include his start date, which is August 31, 2021, indicating the duration of his employment in this position. It also mentions his focus area, highlighting that his teaching and research activities are centered around the pharmaceutical field. Overall, this information provides an overview of his current professional responsibilities and academic focus within the university setting.

Award Participated:

Mr. Shriyansh Srivastava has actively participated in various workshops and conferences to enhance his professional knowledge and skills. He attended a workshop on advanced histopathological techniques using microtome, cryostat, and tissue processor in February 2021. He also presented at the International Conference on “Unlocking Challenges Innovations and Global Opportunities in Research Amidst COVID-19 Pandemic” in December 2020. Additionally, he participated in the 59th National Pharmacy Week 2020 organized by ISF College of Pharmacy, Moga, and attended a one-day international workshop on lung injury therapy in November 2019. He also participated in the 54th IHPA National conference on safe and effective medicine in September 2019 and the 31st Annual Conference of India Pharmacy Graduates Association in April 2017, showcasing his commitment to professional development and staying updated with the latest advancements in the field.

Skills:

Mr. Shriyansh Srivastava possesses a wide range of expertise in laboratory equipment and techniques. He is proficient in operating the Langendroff Apparatus, fluorescent microscope, centrifuge, non-invasive blood pressure apparatus, Eddy’s hot plate, plethysmometer, actophotometer, student organ bath, microtome, and cryostat. He also has experience in handling animals, particularly rats, mice, and guinea pigs. Additionally, he has a strong understanding of histological studies and is skilled in using MS Office applications (Word, Excel, PowerPoint). He is well-versed in safety requirements and laboratory management, ensuring a clean and safe workplace. Furthermore, he is knowledgeable about Windows operating systems and various application software such as ChemDraw, EndNote, and BioRender.

Publications:

  1. Unveiling the potential of proteomic and genetic signatures for precision therapeutics in lung cancer management
    • Authors: S Srivastava, N Jayaswal, S Kumar, PK Sharma, T Behl, A Khalid, …
    • Year: 2024
    • Citations: 7
    • Journal: Cellular Signalling 113, 110932
  2. The Global Monkeypox (Mpox) outbreak: a comprehensive review
    • Authors: S Srivastava, S Kumar, S Jain, A Mohanty, N Thapa, P Poudel, K Bhusal, …
    • Year: 2023
    • Citations: 7
    • Journal: Vaccines 11 (6), 1093
  3. Biodegradable electrospun scaffolds as an emerging tool for skin wound regeneration: A comprehensive review
    • Authors: D Sharma, S Srivastava, S Kumar, PK Sharma, R Hassani, HG Dailah, …
    • Year: 2023
    • Citations: 6
    • Journal: Pharmaceuticals 16 (2), 325
  4. Wnt/β-catenin antagonist pyrvinium rescues high dose isoproterenol induced cardiotoxicity in rats: Biochemical and immunohistological evidences
    • Authors: S Srivastava, S Yadav, G Singh, SS Bajwa
    • Year: 2022
    • Citations: 6
    • Journal: Chemico-Biological Interactions 358, 109902
  5. Evolution of β-catenin-independent Wnt–GSK3–mTOR signalling in regulation of energy metabolism in isoproterenol-induced cardiotoxicity model
    • Authors: S Srivastava, N Bagang, S Yadav, S Rajput, D Sharma, A Dahiya, …
    • Year: 2021
    • Citations: 5
    • Journal: Inflammation Research 70 (7), 743-747
  6. Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation
    • Authors: S Dhoundiyal, S Srivastava, S Kumar, G Singh, S Ashique, R Pal, …
    • Year: 2024
    • Citations: 3
    • Journal: European Journal of Medical Research 29 (1), 26
  7. Emergence of Marburg virus: a global perspective on fatal outbreaks and clinical challenges
    • Authors: S Srivastava, D Sharma, R Rijal, S Adhikari, P Bashyal, JJ Barboza, …
    • Year: 2023
    • Citations: 3
    • Journal: Frontiers in Microbiology 14, 1239079
  8. Platelet‐rich plasma exhibits anti‐inflammatory effect and attenuates cardiomyocyte damage by reducing NF‐κB and enhancing VEGF expression in isoproterenol induced …
    • Authors: S Yadav, S Srivastava, G Singh
    • Year: 2022
    • Citations: 3
    • Journal: Environmental Toxicology 37 (4), 936-953
  9. Recent Nipah virus outbreak in India: lessons and imperatives
    • Authors: S Srivastava, N Deb, P Roy, V Jaiswal, S Sah, Y Pandey, …
    • Year: 2023
    • Citations: 1
    • Journal: Therapeutic Advances in Infectious Disease 10, 20499361231208535
  10. Significant progress in chikungunya Control: FDA approval of Ixchiq vaccine
    • Authors: S Srivastava, S Kumar, P Satapathy, KH Jaaaim, AH Hermis, R Mehta, …
    • Year: 2024
    • Journal: Clinical Infection in Practice, 100351